AIM

#4751
AIM ImmunoTech Inc. Common Stock
0.3 9 USD
-7.14%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.39
0.39
Range Annuel
0.21
20.35
Changement quotidien
-7.14%
Changement Mensuel
-23.54%
Evolution sur 6 mois
-75.65%
Changement Annuel
-95.41%
Clôture Précédente
0.4 2
Open
0.3 9
Low
0.3 9
High
0.3 9
Volume
233
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

AIM ImmunoTech Inc. Common Stock

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Nouvelles